FT : Prosecutors probe for ‘inflated revenue’ at deal-hungry Steinhoff

Prosecutors probe for ‘inflated revenue’ at deal-hungry Steinhoff
Shares plunge as chief executive resigns and results are delayed

German prosecutors say they are investigating whether Steinhoff International inflated its revenue and book value, one day after the global home retailer announced that its longtime chief executive had quit.

Shares in the South African-headquartered, Frankfurt-listed company plunged more than 60 per cent on Wednesday to €1.10 after it delayed its financial results and disclosed it had hired PwC to probe “accounting irregularities”.

The immediate departure of Markus Jooste, who has led the company since 2000, comes after he used a string of acquisitions to build the group into an international powerhouse with 40 brands in 30 countries.

Steinhoff’s board said on Wednesday evening that it was giving “further consideration to the ... validity and recoverability” of €6bn worth of the company’s non-South African assets, and expected to unlock about €3bn in liquidity through asset sales and a refinancing of a South African subsidiary.

Chairman Christo Wiese, one of South Africa’s richest men, took over as interim executive chairman on Wednesday. Ben La Grange remains as chief financial officer; Steinhoff said there was “no evidence to suggest that [he] had any involvement in the matters under investigation”.

Prosecutors in the federal state of Lower Saxony, home of the Steinhoff Europe subsidiary, said on Wednesday: “The suspicion is that inflated revenue numbers made their way into the accounts. This may have led to an inflated book value of the group.”

The investigators are probing whether Steinhoff flattered its numbers by selling intangible assets and partnership shares without disclosing that it had close connections to the buyers. The suspicious sales were in “three-digit million” euros territory each, according to the prosecutors.

“Given the scale of the investigation, its end is not yet in sight,” the office said.

Last year, Steinhoff absorbed the US’s Mattress Firm and Britain’s Poundland in deals that were collectively worth more than £3bn, but early this year it had to call off efforts to merge with South African grocer Shoprite.

The departure of Mr Jooste, who trained as an accountant, comes four months after the prosecutor’s office publicly confirmed it was investigating four current and former Steinhoff executives on suspicion of giving incorrect representations in accounts.

On Tuesday night Steinhoff announced it was hiring PwC and delaying the release of its financial statements until “it is in a position to do so”. It also raised the possibility that it might have to restate financial statements from past years.

Markit, the data provider, said 40 per cent of Steinhoff’s Johannesburg-listed shares were out on loan before Tuesday’s announcement, indicating that a large number of investors were short selling the stock — in effect betting the price will fall. More than a quarter of Steinhoff’s Frankfurt-listed shares were also out on loan, Markit said.

Mr Wiese has been a major shareholder in Steinhoff since 2014, when the German company bought his Pepkor Group clothing chain in a deal that saw the larger company diversify away from its core business of selling discount furniture in Europe.

Last year the billionaire’s family investment vehicle borrowed €1.6bn from banks in order to buy 314m shares in a capital raising by Steinhoff to refinance loans that funded its acquisitions of Poundland and Mattress Firm. The vehicle pledged 628m shares, or 15 per cent of Steinhoff’s share capital at the time, as collateral for the loan, according to a regulatory filing.

Steinhoff said that Pieter Erasmus, former chief executive of Pepkor, would join Mr Wiese to help manage Steinhoff’s global retail interests.

Its board said it wished “to reassure shareholders that Steinhoff has a number of high quality profitable businesses around the world”. It also advised investors “to exercise caution” when dealing in its securities.

The IRBA, the South African accounting regulator, said it was “watching” the developments at Steinhoff closely but that it would be “premature to get involved” at this stage. The body can only investigate an audit firm — not a company — and only gets involved if there is evidence that misconduct by that firm has taken place.

Deloitte was appointed external auditor in 2015 and audited its accounts in 2015 and 2016, according to Steinhoff’s annual reports. It declined to comment citing client confidentiality obligations.

However, the auditor stated in the company’s 2016 report: “Our audit has been performed with a high, but not absolute, level of assurance, which means we may not have detected all errors and fraud.”

Mr Jooste could not be reached for comment.

FT : UK eyes tax boost for asset managers to ease Brexit fears

UK eyes tax boost for asset managers to ease Brexit fears
Ministers to reconsider tax treatment of people working for short periods in Britain

The UK government has published a new strategy paper intended to support the country’s £8.1tn asset management industry, including plans to reconsider the tax treatment of people working for short periods of time in the UK.

Britain’s asset management sector has grown substantially since the financial crisis, and now employs 38,000 people directly and a further 56,000 jobs indirectly, according to the government.

The industry is the second largest in the world, behind the US, with a 36 per cent market share in Europe. But the sector has grappled with Brexit-related uncertainty in recent months, and faces increasingly strong competition from France and Germany.

Chancellor Philip Hammond said on Wednesday that UK asset managers serviced millions of clients and generated about 1 per cent of the nation’s gross domestic product.

“The industry makes an invaluable contribution to the UK economy that must be recognised and built upon,” he said.

The wide-ranging report, published on Wednesday, included a commitment from the government to examine next year whether to overhaul rules for short-term business visitors.

Under the current “60-day rule”, employees of overseas companies that work temporarily in Britain are exempt from UK income taxes, even if they are paid by the UK arm of their employer.

However, employees who work in a foreign branch of a UK-based company and make short business visits to the UK are taxed on their earnings for the time spent working in Britain.

The industry has lobbied heavily for the system to be changed. The government said in Wednesday’s report that the current scheme “creates an administrative burden for the UK company, which has to account for ‘pay as you earn’ on foreign-paid earnings for the period of time spent working here”.

Stephen Barclay, the City minister, said: “The UK is a world leader in asset management, and it is vital that we keep it that way. The government will come to a view, in spring, on whether to consult on making changes to the short term visitors rules in this area.”

Chris Cummings, chief executive of the Investment Association trade body, welcomed the report, saying it would give the asset management industry the “road map” it needed to navigate Brexit.

The paper also called for more concerted efforts to encourage asset managers based overseas to operate in the UK, as well as more backing for domestic asset managers developing innovative investment strategies, such as green finance and “social impact” investing.

The report also included a commitment to “strengthen the UK’s asset management talent pipeline” by working with British universities and promoting so-called fintech initiatives, such as a blockchain-enabled digital fund. The paper also said the government would build on the work of the asset management task force, which was launched in October to promote communication between government, regulators and industry.

David Cameron’s coalition government first launched an official investment management strategy in 2013, intended to increase the number of funds domiciled in the UK. That strategy has been widely seen as a success. In 2013, the sector had £5tn under management; the industry currently has £8.1tn under management.

>>> lululemon athletica Earnings Preview

lululemon athletica Earnings Preview (66.69 +0.33)

lululemon athletica (LULU) is set to report Q3 earnings after the market closes today (the co reported at 16:05 last quarter) with a conference call to follow at 4:30 PM ET. Current Capital IQ estimates Q3 diluted EPS of $0.52 (vs $0.47 last year) on revs +12% Y/Y to $610 mln. Estimates for total comps is +5.2%

The Co typically provides guidance for the next quarter and FY in the press release.
Current Cap IQ estimates Q4 EPS of $1.17 on revs +10% Y/Y to $866 mln
Current Estimates are for comps of 4.3%
Last quarter the co reported beat on both EPS and revs and provided upside guidance.
Direct to consumer net revenue (e-commerce) +29% or 16% excluding impact of warehouse sale
Q3 Guidance: EPS of $0.50-0.52, excluding non-recurring items, on Revs of $605-615 mln.
Expects Q3 comps increase of mid single digit range ex-fx
FY 18 Guidance: EPS of $2.35-2.42, excluding ivivva restructuring impact
Expects comps to increase in the lsd range on a constant dollar basis
Expects revs of $2.545-2.595 bln
Comps increase in the low single-digit range on a constant dollar basis

Musings on LULU before the report

LULU has had a pretty up and down year. Investors were not very pleased w/ its Q4 report from 2016 as shares fell 24%. Shares eventually reached 52-week lows at around 47.26 on May 31, a couple days before Q1s report. Since then, LULU shares have been slowly filling that gigantic gap and are currently trading at around where LULU was trading before the huge drop.
During its Q2 call, mgmt. spoke about the acceleration the co's business was seeing from the initiatives that were undertaken/announced during the Q1 report (see LULU's Q2 earnings preview for a more in-depth look into those initiatives).

Conclusion: Q2 was an impressive report and hinted that mgmt's initiatives/new products have reignited momentum in the co's business. The stock beat estimates and posted a gross margin of 51.2%. Despite the report, investors did not seem too sold on the comeback story as shares continued trading up and down throughout the quarter before breaking through $64 resistance on November 10. Investors are no doubt scared of another gap down happening due to poor earnings from the co as volume has essentially dried up heading into the report.

Slower/bigger institutional funds may need another strong report before becoming believers again in the story though. Thus, this quarter is starting to shape-up as a prove-it/confirmation quarter of sorts as investors will be looking to see if the acceleration of momentum carried over into Q3

>>> US Gapping down

Gapping down
In reaction to disappointing earnings/guidance
:
  • LQDT -17.4%, FRED -11.6%, VEEV -4.6%, VNET -2.6%, HD -2.1% (guidance), RH -1.8%, HQY -1.4%
Other news:
  • TROX -21.5% (FTC merger challenge alleging that combining Tronox and Cristal would reduce competition; administrative trial is scheduled to begin on May 8, 2018), CUR -15.2% (after closing near highs -- up 175%)
  • BBG -12.6% (prices 21 mln shares of common stock)
  • VKTX -12% ( intends to offer shares of common stock in underwritten public offering)
  • EDIT -4.2% (prices underwritten offering of 1.97 mln shares of its common stock)
  • GWPH -2.1% (to sell $225 mln of American Depositary Shares representing ordinary shares an underwritten U.S. public offering)
  • TRHC -2.1% (prices offering by co and selling shareholders of 3 mln shares of common stock at $27.50 per share)
  • EIX -1.6% (modestly rebounding; has been periodically issuing updates on outages and wildfires)
  • RVNC -1.3% (Revance Therapeutics proposed offering of $175 mln in common stock and 600K shares by selling stockholders; also files mixed securities shelf offering), KSHB -0.9% ( files for $100 mln mixed securities shelf offering)
Analyst comments:
  • PDCO -3.7% (downgraded to Underweight from Equal-Weight at Morgan Stanley)
  • VNTR -3.7% (downgraded to Neutral from Buy at Goldman)
  • HSIC -3% (downgraded to Underweight from Equal-Weight at Morgan Stanley)
  • SNAP -2.4% (initiated with a Underperform at Evercore ISI; tgt $7)
  • EIX -1.6% (downgraded to Neutral from Buy at Mizuho)

>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance
:
  • AVAV +21.4%, ZX +21.2%, SCWX +14.5%, PLAY +7.3%, (also introduces new smaller store format of 15,000 to 20,000 square feet ), FNKO +4.3%, AEO +3.4%
M&A news:
  • CLNT +110.9% (to acquire a 51% interest in the issued share capital of Brighten Holdings)
  • DVA +8.8% (to sell its DaVita Medical Group unit to UnitedHealth's (UNH) Optum for approximately $4.9 bln in cash)
Other news:
  • CLRB +25% (announces that the company will increase the targeted patient enrollment in the relapsed/refractory (R/R) multiple myeloma (MM) cohort of its currently enrolling Phase 2 clinical trial of CLR 131)
  • ARWR +10.5% (Presents New Clinical Data Demonstrating a Sustained Host Response in Hepatitis B Patients Following RNAi Therapy)
  • NXTD +10.2% (Nxt-ID's Fit Pay and Garmin announced that the Garmin Pay contactless payment feature is now available for eligible Visa (V) accounts)
  • GLBL +4.8% (TerraForm Global exercised right to extend termination date under Brookfield Asset Management (BAM) agreement and plan of merger to March 6, 2018 from December 6, 2017 )
  • MYOS +4.7% (enters research agreement with the University of California)
  • CHRS +2.9% (Coherus BioSciences discloses entry into Stock Purchase Agreement with KBI Biopharma)
  • DISCA +2.5% (Guy Adami appeared on CNBC Fast Money with another 'Fast Pitch' -- this time on DISCA)
  • AYX +2.5% (CEO featured on Tuesday's Mad Money)
  • CLVS +2.3% ( FDA has accepted its sNDA for rucaparib and granted priority review status to the application with a PDUFA date of April 6, 2018)
  • TIVO +2.2% (CEO/Pres disclosed the purchase of nearly 56K shares worth approx $999.6K)
Analyst comments:
  • NVO +2.9% (upgraded to Buy from Neutral at BofA/Merrill)
  • PEGI +1.5% (upgraded to Buy from Neutral at Goldman)
  • CCL +0.9% (upgraded to Equal-Weight from Underweight at Morgan Stanley)